Norsk Patenttidende nr 09/05 - Patentstyret
Norsk Patenttidende nr 09/05 - Patentstyret
Norsk Patenttidende nr 09/05 - Patentstyret
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
allment tilgjengelige patentsøknader (A) 20<strong>05</strong>.02.28 - <strong>nr</strong> <strong>09</strong>/<strong>05</strong><br />
(51) Klasse : C07D 207/327<br />
(21) Søknads<strong>nr</strong> : 20043842<br />
(22) Inndag : 2004.<strong>09</strong>.14<br />
(41) Allm.tilgj : 2004.<strong>09</strong>.14<br />
(30) Prioritet : 2002.02.15, US, 357181<br />
2002.11.12, US, 425325<br />
(86) Int.inndag : 2003.02.19<br />
(86) Int.søknads<strong>nr</strong> : PCT/US03/<strong>05</strong>384<br />
(24) Løpedag 2003.02.19<br />
(71) Søker<br />
Teva Pharmaceutical Industries Ltd , P O Box 3190,<br />
49131 PETAH TIQVA, IL<br />
(74) Fullmektig<br />
Tandbergs Patentkontor AS , Postboks 7085 Majorstua,<br />
0306 OSLO, NO<br />
(72) Oppfinner<br />
Judith Aronhime, Rehov Harav Maor-Iosef 5A, REHOVOT,<br />
76217, IL<br />
Revital Lifshitz-Liron, 12A Kibbush H'aavoda Street, Apt<br />
#8, HERZLIA, 46322, IL<br />
Dalia Maidan-Hanoch, 50 Sigalon Str, KFAR YONA, IL<br />
Limor Tessler, 61/11 Petach-Tikva Str., NATANYA, 42380,<br />
IL<br />
Nir Hasson, Grar 13, MEITAR, 85025, IL<br />
(54) Benevnelse<br />
Nye krystallformer av atorvastatinhemikalsium og<br />
fremgangsmåter for fremstilling derav, såvel som nye<br />
fremgangsmåter for fremstilling av<br />
atorvastatinhemikalsiumform I, VIII og IX<br />
(51) Klasse : C07D 2<strong>09</strong>/10<br />
(21) Søknads<strong>nr</strong> : 20044031<br />
(22) Inndag : 2004.<strong>09</strong>.24<br />
(41) Allm.tilgj : 2004.10.19<br />
(30) Prioritet : 2002.03.26, US, 367758<br />
2002.12.<strong>09</strong>, US, 431817<br />
2003.01.24, US, 442404<br />
(86) Int.inndag : 2003.03.21<br />
(86) Int.søknads<strong>nr</strong> : PCT/US03/08901<br />
(24) Løpedag 2003.03.21<br />
(71) Søker<br />
Boehringer Ingelheim Pharmaceuticals Inc , P O Box 368,<br />
CT06877 RIDGEFIELD, US<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Younes Bekkali, c/o Boehringer Ingelheim<br />
Pharmaceuticals Inc., 900 Ridgebury Road, RIDGEFIELD,<br />
CT06877-036, US<br />
Raj Betageri, c/o Boehringer Ingelheim Pharmaceuticals<br />
Inc., 900 Ridgebury Road, RIDGEFIELD, CT06877-036,<br />
US<br />
Thomas A Gilmore, 12 Andover Street, SALEM,<br />
MA01970, US<br />
Mario G Cardozo, 579 Mramar Avenue, SAN<br />
FRANCISCO, CA94112, US<br />
Thomas M Kirrane, c/o Boehringer Ingelheim<br />
Pharmaceuticals Inc., 900 Ridgebury Road, RIDGEFIELD,<br />
CT06877-036, US<br />
Daniel Kuzmich, c/o Boehringer Ingelheim<br />
Pharmaceuticals Inc., 900 Ridgebury Road, RIDGEFIELD,<br />
CT06877-036, US<br />
John Robert Proudfoot, c/o Boehringer Ingelheim<br />
Pharmaceuticals Inc., 900 Ridgebury Road, RIDGEFIELD,<br />
CT06877-036, US<br />
Hidenori Takahashi, c/o Boehringer Ingelheim<br />
Pharmaceuticals Inc., 900 Ridgebury Road, RIDGEFIELD,<br />
CT06877-036, US<br />
David Thomson, c/o Boehringer Ingelheim<br />
Pharmaceuticals Inc., 900 Ridgebury Road, RIDGEFIELD,<br />
CT06877-036, US<br />
Ji Wang, c/o Boehringer Ingelheim Pharmaceuticals Inc.,<br />
900 Ridgebury Road, RIDGEFIELD, CT06877-036, US<br />
Renee Zindell, c/o Boehringer Ingelheim Pharmaceuticals<br />
Inc., 900 Ridgebury Road, RIDGEFIELD, CT06877-036,<br />
US<br />
Christian Hanke Justus Joachim Harcken, c/o Boehringer<br />
Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road,<br />
RIDGEFIELD, CT06877-036, US<br />
Doris Riether, c/o Boehringer Ingelheim Pharmaceuticals<br />
Inc., 900 Ridgebury Road, RIDGEFIELD, CT06877-036,<br />
US<br />
(54) Benevnelse<br />
Glukocorticoid-mimetica, fremgangsmåter for fremstilling<br />
av dem, farmasøytiske blandinger og anvendelser derav<br />
101
Change language